Which fiber-capsule formula does the record describe?

“Fiber capsules” names a format and a broad commercial category. It does not distinguish Full House’s proprietary mixture from Swanson SW993, with its three separately weighted ingredients, or NOW’s psyllium capsule. Even within one brand, a different strength or plant preparation may have a different facts panel. Keeping the full product name and item number avoids quietly transferring a finding from one page to another. This is especially important when a search snippet shortens a title. The Swanson review is deliberately tied to Tri-Fiber Complex SW993, rather than treating the brand’s separate psyllium products as interchangeable evidence.

NOW’s official size table distinguishes 200-capsule SKU 5970 from 500-capsule SKU 5972. Its displayed facts panel identifies the smaller package, while the page offers both sizes. That relationship should remain visible when a reviewer quotes a price, serving count or label image. It does not prove which stock is available at a particular destination or which package would be dispatched. The NOW review preserves the version alongside each observation. A larger container can share the same product family without allowing every detail of one photograph to substitute for the other package’s current label or a selected cart.

NIH’s supplement overview explains that labels include other ingredients such as fillers, binders and flavorings. Those entries are part of the record, even when marketing emphasizes only a featured botanical. Full House’s published panel, for example, names the capsule material and additional ingredients outside its proprietary blend. The presence of those names does not independently establish a health benefit or a safety problem. It does prevent the phrase “four ingredients” from being mistaken for an exhaustive description of everything in the finished capsule. A formula discussion should specify whether it means featured dietary components or the complete published ingredient declaration.

The NOW web record currently says that traces of sesame may be present. The label artwork linked from the same page includes sesame in its not-manufactured-with ingredient list and also carries a facility qualification. This review cannot reconcile those statements for a delivered bottle. Reporting the disagreement is more accurate than choosing whichever wording appears newer or more reassuring without confirmation. Swanson’s SW993 record separately declares wheat; its vegan capsule description does not negate that statement. These are questions about product-specific records. They are not a basis for this publication to decide whether either preparation is suitable for someone with an allergy.

The NOW warning connects insufficient liquid with choking risk and says the product should not be taken when swallowing is difficult. Full House’s offer likewise contains swallowing and gastrointestinal restrictions and medicine-related cautions. Preserving the exact source matters: a warning from a different preparation should not be silently substituted, and a general comfort claim should not dilute a warning that is present. The fullness guide addresses the danger of treating discomfort as a desired effect. A professional discussion can use the current label, but this static article cannot assess symptoms or decide how a capsule should be taken.

FDA’s consumer guidance explains its role in supplement oversight and the absence of premarket approval for supplement safety and effectiveness. A facility-registration statement does not mean an individual product has that approval. Likewise, a label image is a manufacturer-published illustration, not a chain of custody for a customer’s container. Our review does not inspect lot records, independently analyze ingredients or verify distribution. The ingredient-research guide draws a related distinction when a paper reports testing its own study material: that evidence cannot become a quality claim about unrelated current bottles merely because their ingredient names overlap.

The seller or manufacturer can address an item number, label revision, package discrepancy or unclear order selection. A pharmacist or clinician addresses the significance of ingredients and warnings in a person’s circumstances. MedlinePlus’s psyllium information emphasizes sharing medicines and supplements with healthcare professionals; it does not let a web reviewer clear combinations from a category name. The Full House review keeps supply and refund questions separate from clinical ones for the same reason. An organized product record improves a conversation by reducing ambiguity. It does not replace professional assessment or prove that an unidentified, damaged or differently labeled container is acceptable to use.